drugset / Trial / NCT04179396
Study of Oral Rucaparib With Other Anticancer Agents in Metastatic Castration Resistant Prostate Cancer Patients (RAMP)
Non-randomizedParallel-groupOpen-labelTreatment
Summary
Assess the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of Oral Rucaparib in Combination with Other Anticancer Agents in Patients with Metastatic Castration Resistant Prostate Cancer
Timeline
- Start
- 2019-12-05
- Primary completion
- 2021-11-25
- Completion
- 2023-01-18
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Abiraterone acetate | Small molecule | — | Oral |
| Subject | Enzalutamide | Other / unclassified | — | Oral |
| Subject | Rucaparib | Small molecule | — | Oral |